• SEMAGLUTIDE

    Consent form
  • Semaglutide is a human-based glucagon-like peptide-1 receptor agonist prescribed as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) considered outside a healthy range.

     

  • Format: (000) 000-0000.
  • Do not take this medication if:

    ♣ You have a personal or family history of medullary thyroid carcinoma (Thyroid Cancer)

    ♣ Multiple Endocrine Neoplasia syndrome type 2

    ♣ You are pregnant or plan to become pregnant while taking this medicine.

    ♣ You are diabetic and/or taking any medications related to lowering your blood sugar levels without speaking with your endocrinologist.

    ♣ Specifically, if you are prescribed Insulin because the combination may increase your risk of hypoglycemia (low blood sugar) and dosage adjustments by your provider may be necessary.

    ♣ You have a history of Pancreas.

    ♣ You are allergic to BPC-157, Semaglude or any other GLP-1 agonist such as: Adlyxin®, Byeta®,

    Bydureon®, Ozempic®, Rybelsus®, Trulicity®, Victoza®, Wegovy®;

    ♣ If you have other allergies. This product may contain inactive ingredients, which can cause allergic eacons or other problems. Talk to your pharmacist for more details. Before using this medicaon, tell your doctor/pharmacist your medical history.

     

  • Possible drug interactions: Antidiabetic agents, specifically Insulin and Sulfonylureas (e.g., glyburide, glipizide, glimepiride, tolbutamide) due to the increased risk of hypoglycemia (low blood sugar). Do not take with other GLP-1 agonist medicines such as: Adlyxin®, Byeta®, Bydureon®, Ozempic®, Rybelsus®, Trulicity®, Victoza®, Wegovy® (THIS IS NOT AN ALL-INCLUSIVE LIST). For other medications used in diabetes, please tell your provider about any medications that may lower your blood sugar.

    Possible side effects: Nausea, diarrhea, vomiting, constant abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, belching, hypoglycemia, flatulence, gastroenteritis, and gastroesophageal reflux disease. Subcutaneous Injections: common injection site reactions characterized by itching and burning at the administration site with or without skin thickening (well). Contact your doctor or pharmacist if you see other side effects not listed above.

    A very serious allergic reaction to this drug is rare. However, get medical help immediately if you notice any symptoms of a serious allergic reaction, including rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing. Report adverse side effects to your doctor or pharmacist. In the event of any emergency, call 911 immediately.

     

     

  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Powered by Jotform SignClear
  • Should be Empty: